
Perspectives on Prostate Disease: Volume 3, Issue 3
Did you know?
You can get instant online access to all of the articles from Volume 3 Issue 3 of Perspectives on Prostate Disease for only $25.00.
Already a subscriber to this newsletter? Login for complete instant access.
Articles in this issue:
The ongoing debate continues
A message from Editor in Chief Marc Garnick, M.D. about the conflicting results from two prostate cancer studies and what this may mean for men considering a PSA test, and previews of other articles in this issue.
PSA screening: What doctors tell their patients
Harvard physicians share their thoughts on PSA screening and two recent studies that aimed to determine whether screening saves lives.
PSA screening for prostate cancer
Two studies come to different conclusions about the benefits, leaving patients and their doctors to decide what makes sense.
Might cholesterol-lowering drugs drop prostate cancer risk, too?
Several studies of statins come to optimistic conclusions.
Stress and benign prostatic hyperplasia (BPH)
Science shows there may be a connection.
Prostate cancer and relationships: The partner's story
Three women talk about how prostate cancer affected their intimate relationships, and offer advice for spouses and girlfriends just beginning their prostate cancer journey.
Experimental therapies for prostate cancer
Abiraterone and MDV3100 may slow disease progression.
Advances and breakthroughs in prostate disease
A roundup of recent advances in the understanding and treatment of prostate disease.
Ask the doctor
Answers to your questions on prostate health. In this edition, Perspectives' editorial board member William C. DeWolf, M.D. responds to questions about age as a factor in the decision to have a radical prostatectomy and concern about a "PSA bounce."
Searching PubMed in five easy steps
Brief instructions for using the PubMed database to read more detailed information about the studies cited in Perspectives on Prostate Disease, so you can evaluate the evidence on your own.
